Northeast Financial Consultants’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,210
| Closed | -$228K | – | 285 |
|
|
2023
Q3 | $228K | Hold |
2,210
| – | – | 0.01% | 252 |
|
|
2023
Q2 | $269K | Hold |
2,210
| – | – | 0.02% | 241 |
|
|
2023
Q1 | $339K | Hold |
2,210
| – | – | 0.02% | 235 |
|
|
2022
Q4 | $397K | Hold |
2,210
| – | – | 0.03% | 218 |
|
|
2022
Q3 | $261K | Buy |
+2,210
| New | +$261K | 0.02% | 282 |
|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$254K | – | 398 |
|
|
2021
Q4 | $254K | Sell |
1,000
-2,400
| -71% | -$610K | 0.02% | 306 |
|
|
2021
Q3 | $1.31M | Buy |
3,400
+2,400
| +240% | +$924K | 0.09% | 132 |
|
|
2021
Q2 | $235K | Buy |
+1,000
| New | +$235K | 0.02% | 322 |
|